• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-CXCL16

CXCL16 Monoclonal Antibody for WB,ELISA

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain, souris et plus (1)

Applications

WB, IHC, IF, ELISA

Conjugaison

Non conjugué

CloneNo.

2H7B3

N° de cat : 60123-1-Ig

Synonymes

C X C motif chemokine 16, CXCL16, CXCLG16, SCYB16, Small inducible cytokine B16, SR PSOX, SRPSOX, Transmembrane chemokine CXCL16



Applications testées

Résultats positifs en WBcellules SH-SY5Y

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:200-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

60123-1-Ig cible CXCL16 dans les applications de WB, IHC, IF, ELISA et montre une réactivité avec des échantillons Humain, souris

Réactivité Humain, souris
Réactivité citéerat, Humain, souris
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène CXCL16 Protéine recombinante Ag4883
Nom complet chemokine (C-X-C motif) ligand 16
Masse moléculaire calculée 273 aa, 30 kDa
Poids moléculaire observé 35 kDa, 60 kDa
Numéro d’acquisition GenBankBC017588
Symbole du gène CXCL16
Identification du gène (NCBI) 58191
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Précipitation de l'acide caprylique/du sulfate d'ammonium
Tampon de stockage PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

CXCL16 is a recently discovered cytokine belonging to the CXC chemokine family, which is synthesised in plasmacytoid dendritic cell as a transmembrane molecule. It exists in a transmembrane and soluble form. The transmembrane form of CXCL16 functions as an adhesion molecule for CXCR6-expressing cells, whereas the soluble form of CXCL16 mediates infiltration of circulating cells into sites of injury. CXCL16, has been proposed as an important pathogenic mediator in inflammatory diseases, including rheumatoid arthritis, glomerulonephritis, or prostate cancer. CXCL16 has been implicated in some forms of renal disease such as lupus nephritis and antiglomerular basement membrane nephritis. CXCL16 also plays a pivotal role in the pathogenesis of angiotensin II-induced renal injury and fibrosis through regulation of macrophage and T cell infiltration and bone marrow-derived fibroblast accumulation.

Protocole

Product Specific Protocols
WB protocol for CXCL16 antibody 60123-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
ratIHC

Cancer Commun (Lond)

Activation of Piezo1 contributes to matrix stiffness-induced angiogenesis in hepatocellular carcinoma

Authors - Miao Li
mouseWB

FASEB J

Pathogenic Tconvs promote inflammatory macrophage polarization through GM-CSF and exacerbate abdominal aortic aneurysm formation.

Authors - Dan Li
mouseWB

Mol Med Rep

oxLDL promotes podocyte migration by regulating CXCL16, ADAM10 and ACTN4.

Authors - Yuan Chen
  • KO Validated
human,mouseIF

Cardiovasc Diabetol

Klotho inhibits renal ox-LDL deposition via IGF-1R/RAC1/OLR1 signaling to ameliorate podocyte injury in diabetic kidney disease

Authors - Wei Jiang